Ron Finklestien

The Fiscal and Monetary Policy Conundrum

This article delves into the glaring divergence between U.S. fiscal policy and U.S. monetary policy over the past...

The Surprises of Wall Street: An Intriguing Start to 2024 The Surprises of Wall Street: An Intriguing Start to 2024

“Assume life will be really tough, and then ask if you can handle it. If the answer is yes, you’ve won.” - Charlie Munger Investors have flipped the calendar to a new year, hoping for a fresh...

Analyst Bullish On Phathom Pharmaceuticals Expert Analyst Sees Bright...

Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc.PHAT, raising the price target to $26 from $23. ...

Unearthing Freeport-McMoRan’s Potential in the Copper Market

Exploring Freeport-McMoRan's Indelible Infrastructure Freeport-McMoRan (NYSE:FCX), a...